Non-small cell lung cancer (NSCLC) remains the most prevalent type of lung cancer and a leading cause of cancer-related mortality worldwide. Surgical ...
Six-month results from U.S. clinical study show promise for the innovative technology in patients with stage IV non-small cell lung cancer or lung metastasis REDWOOD CITY, Calif., Nov. 11, 2025 ...
July 19, 2006 –- Patients with early-stage non–small cell lung cancer who are not candidates for surgery now have other noninvasive and potentially lifesaving options. In a paper published in the July ...
Activated Src kinase is expressed in malignant pleural mesothelioma tumors; dasatinib inhibition leads to cytotoxicity, cell cycle inhibition, and prevention of invasion and migration No significant ...
One thing that we're seeing is lung cancers being diagnosed earlier and earlier, whereas, historically, 75% of lung cancers ...
Background: Laser ablation (LA) offers advantages such as shorter ablation time and impedance independent, which has received significant attention for the treatment of lung cancers. However, the ...
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...
Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to immunosuppression and cancer progression. While these macrophages typically accumulate ...
While therapies continue to improve, prevention remains the strongest line of defense. Stopping smoking dramatically lowers ...
AerWave Medical has concluded the feasibility study of its ultrasound lung denervation therapy, designed to treat chronic obstructive pulmonary disease (COPD) and asthma. The first-in-human study, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback